R. Agami, G. Blandino, M. Oren, and Y. Shaul, Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis, Nature, vol.399, pp.809-813, 1999.

J. Bartek, J. Bartkova, B. Vojtesek, Z. Staskova, J. Lukas et al., Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies, Oncogene, vol.6, pp.1699-1703, 1991.

J. Bartek, J. Bartkova, B. Vojtesek, Z. Staskova, A. Rejthar et al., Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro, Int. J. Cancer, vol.46, pp.839-844, 1990.

L. Buckbinder, R. Talbott, S. Velasco-miguel, I. Takenaka, B. Faha et al., Induction of the growth inhibitor IGF-binding protein 3 by p53, Nature, vol.377, pp.646-649, 1995.

A. N. Bullock, J. Henckel, B. S. Dedecker, C. M. Johnson, P. V. Nikolova et al., Thermodynamic stability of wild-type and mutant p53 core domain, Proc. Natl. Acad. Sci. USA, vol.94, pp.14338-14342, 1997.

A. N. Bullock, J. Henckel, and A. R. Fersht, Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy, Oncogene, vol.19, pp.1245-1256, 2000.

I. Casciano, M. Ponzoni, C. Cunsolo, G. Tonini, and M. Romani, Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma, Cell Death Differ, vol.6, pp.391-393, 1999.

J. Celli, P. Duijf, B. C. Hamel, M. Bamshad, B. Kramer et al., Cell, vol.99, pp.143-153, 1999.

X. Chen, L. J. Ko, L. Jayaraman, and C. Prives, p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells, Genes Dev, vol.10, pp.2438-2451, 1996.

Y. Cho, S. Gorina, P. D. Jeffrey, and N. P. Pavietich, Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations, Science, vol.265, pp.346-355, 1994.

T. Crook, J. M. Nicholls, L. Brooks, J. O'nions, and M. J. Allday, High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?, Oncogene, vol.19, pp.3439-3444, 2000.

T. S. Davison, C. Vagner, M. Kaghad, A. Ayed, D. Caput et al., Arrowsmith. 1999. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53, J. Biol. Chem, vol.274, pp.18709-18714

V. De-laurenzi, A. Costanzo, D. Barcaroli, A. Terrinoni, M. Falco et al., Two new p73 splice variants, gamma and delta, with different transcriptional activity, J. Exp. Med, vol.188, pp.1763-1768, 1998.

C. J. Di-como, C. Gaiddon, and C. Prives, p73 function is inhibited by tumor-derived p53 mutants in mammalian cells, Mol. Cell. Biol, vol.19, pp.1438-1449, 1999.
URL : https://hal.archives-ouvertes.fr/inserm-02360310

K. Ejeskar, R. M. Sjoberg, P. Kogner, and T. Martinsson, Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development, Int. J. Mol. Med, vol.3, pp.585-589, 1999.

W. S. El-deiry, S. E. Kern, J. A. Pietenpol, K. W. Kinzier, and B. Vogelstein, Definition of a consensus binding site for p53, Nat. Genet, vol.1, pp.45-49, 1992.

C. Gaiddon, A. Boutillier, D. Monnier, L. Mercken, and J. Loeffler, Genomic effects of the putative oncogene G alpha s: chronic transcriptional activation of the c-fos proto-oncogene in endocrine cells, J. Biol. Chem, vol.269, pp.22663-22671, 1994.

J. V. Gannon, R. Greaves, R. Iggo, and D. P. Lane, Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form, EMBO J, vol.9, pp.1595-1602, 1990.

J. G. Gong, A. Costanzo, H. Q. Yang, G. Mellno, W. G. Kaelin et al., The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage, Nature, vol.399, pp.806-809, 1999.

M. Gottlieb and M. Oren, Biochim. Biophys. Acta, vol.1287, pp.77-102, 1996.

T. D. Halazonetis, L. J. Davis, and A. N. Kandil, Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA, EMBO J, vol.12, pp.1021-1028, 1993.

P. A. Hall, S. J. Campbell, M. O'neill, D. J. Royston, K. Nylander et al., Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic cells, Carcinogenesis, vol.21, pp.153-160, 2000.

S. Han, S. Semba, T. Abe, N. Makino, T. Furukawa et al., Infrequent somatic mutations of the p73 gene in various human cancers, Eur. J. Surg. Oncol, vol.25, pp.194-198, 1999.

P. W. Hinds, C. A. Finlay, A. B. Frey, and A. J. Levine, Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines, Mol. Cell. Biol, vol.7, pp.2863-2869, 1987.

P. Ianakiev, M. W. Kilpatrick, I. Toudjarska, D. Basel, P. Beighton et al., Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27, Am. J. Hum. Genet, vol.67, pp.59-66, 2000.

S. Ichimiya, Y. Nimura, H. Kageyama, N. Takada, M. Sunahara et al., Caput, and A. Nakagawara. 1999. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent, Oncogene, vol.18, pp.1061-1066

J. Jayaraman and C. Prives, Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus, Cell, vol.81, pp.1021-1029, 1995.

L. Jayaraman, E. Freulich, and C. Prives, Functional dissection of p53 tumor suppressor protein, Methods Enzymol, vol.283, pp.245-256, 1997.

C. A. Jost, M. C. Marin, and W. G. Kaelin, p73 is a human p53-related protein that can induce apoptosis, Nature, vol.389, pp.191-194, 1997.

W. G. Kaelin and . Jr, Another p53 Doppelganger?, Science, vol.281, pp.57-58, 1998.

M. Kaghad, H. Bonnet, A. Yang, L. Creancier, J. C. Biscan et al.,

. Caput, Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers, Cell, vol.90, pp.809-819, 1997.

L. J. Ko and C. Prives, p53: puzzle and paradigm, Genes Dev, vol.10, pp.1054-1072, 1996.

S. Kovalev, N. Marchenko, S. Swendeman, M. Laquaglia, and U. M. Moll, Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines, Cell Growth Differ, vol.9, pp.897-903, 1998.

Y. Legros, A. Meyer, K. Ory, and T. Soussi, Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein, Oncogene, vol.9, pp.3689-3694, 1994.

A. J. Levine, p53, the cellular gatekeeper for growth and division, Cell, vol.88, pp.323-331, 1997.

M. Levrero, . V.-de, A. Laurenzi, J. Costanzo, J. Y. Gong et al., The p53/p63/p73 family of transcription factors: overlapping and distinct functions, J. Cell Sci, vol.113, pp.1661-1670, 2000.

M. C. Marin, C. A. Jost, L. A. Brooks, M. S. Irwin, J. O'nions et al., A common polymorphism acts as an intragenic modifier of mutant p53 behaviour, Nat. Genet, vol.25, pp.47-54, 2000.

A. A. Mills, B. Zheng, X. J. Wang, H. Vogel, D. R. Roop et al., p63 is a p53 homologue required for limb and epidermal morphogenesis, Nature, vol.398, pp.708-713, 1999.

J. Milner, Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes, Nature, vol.310, pp.143-145, 1984.

J. Milner and E. A. Medcalf, Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation, Cell, vol.65, pp.765-774, 1991.

T. Miyashita and J. C. Reed, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, vol.80, pp.293-299, 1995.

Y. Nimura, M. Mihara, S. Ichimiya, S. Sakiyama, N. Seki et al., Ping, and A. Nakagawara. 1998. p73, a gene related to p53, is not mutated in esophageal carcinomas, Int. J. Cancer, vol.78, pp.437-440

S. Nomoto, N. Haruki, M. Kondo, H. Konishi, and T. Takahashi, Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers, Cancer Res, vol.58, pp.1380-1383, 1998.

K. Nylander, P. J. Coates, and P. A. Hall, Characterization of the expression pattern of p63alpha and deltanp63alpha in benign and malignant oral epithelial lesions, Int. J. Cancer, vol.87, pp.368-372, 2000.

K. Okamoto and C. Prives, A role of cyclin G in the process of apoptosis, Oncogene, vol.18, pp.4606-4615, 1999.

M. Oren, Lonely no more: p53 finds its kin in a tumor suppressor haven, Cell, vol.90, pp.829-832, 1997.

M. Osada, M. Ohba, C. Kawahara, C. Ishioka, R. Kanamaru et al., Cloning and functional analysis of human p51, which structurally and functionally resembles p53, Nat. Med, vol.4, pp.839-843, 1998.

B. J. Park, S. J. Lee, J. I. Kim, C. H. Lee, S. G. Chang et al., Frequent alteration of p63 expression in human primary bladder carcinomas, Cancer Res, vol.60, pp.3370-3374, 2000.

O. Pinhasi-kimhi, D. Michalovitz, A. Ben-zeev, and M. Oren, Specific interaction between the p53 cellular tumour antigen and major heat shock proteins, Nature, vol.320, pp.182-184, 1986.

J. Roth, P. Koch, A. Contente, and M. Dobbeistein, Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain, Oncogene, vol.19, pp.1834-1842, 2000.

H. Schmale and C. Bamberger, A novel protein with strong homology to the tumor suppressor p53, Oncogene, vol.15, pp.1363-1367, 1997.

M. Senoo, N. Seki, M. Ohira, S. Sugano, M. Watanabe et al.,

Y. Tanaka, H. Shinkai, and . Kato, A second p53-related protein, p73L, with high homology to p73, Biochem. Biophys. Res. Commun, vol.248, pp.603-607, 1998.

S. Y. Shieh, J. Ahn, K. Tamal, Y. Taya, and C. Prives, The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites, Genes Dev, vol.14, pp.289-300, 2000.

T. J. Silhavy, M. L. Berman, and L. W. Enquist, Experiments with gene fusions, 1984.

S. Strano, E. Munarriz, M. Rossi, B. Cristofanelli, Y. Shaul et al., Physical and functional interaction between p53 mutants and different isoforms of p73, J. Biol. Chem, vol.275, pp.29503-29512, 2000.

M. Sunahara, S. Ichimiya, Y. Nimura, N. Takada, S. Sakiyama et al., Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas, Int. J. Oncol, vol.13, pp.319-323, 1998.

A. Tannapfel, M. Wasner, K. Krause, F. Geissler, A. Katalinic et al., Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma, J. Natl. Cancer Inst, vol.91, pp.1154-1158, 1999.

B. Vojtesek, H. Dolezalova, L. Lauerova, M. Svitakova, P. Havlis et al., Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein, Oncogene, vol.10, pp.389-393, 1995.

E. White and C. Prives, DNA damage enables p73, Nature, vol.399, pp.734-737, 1999.

K. Yamaguchi, L. Wu, O. L. Caballero, K. Hibi, B. Trink et al., Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma, Int. J. Cancer, vol.86, pp.684-689, 2000.

A. Yang, M. Kaghad, Y. Wang, E. Gillett, M. D. Fleming et al., p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities, Mol. Cell, vol.2, pp.305-316, 1998.

A. Yang, R. Schweitzer, D. Sun, M. Kaghad, N. Walker et al., p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development, Nature, vol.398, pp.714-718, 1999.

A. Yang, N. Walker, R. Bronson, M. Kaghad, M. Oosterwegel et al., p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours, Nature, vol.404, pp.99-103, 2000.

A. Yokomizo, M. Mai, D. J. Tindall, L. Cheng, D. G. Bostwick et al., Overexpression of the wild type p73 gene in human bladder cancer, Oncogene, vol.18, pp.1629-1633, 1999.

H. Yokozaki, Y. Shitara, J. Fujimoto, T. Hiyama, W. Yasui et al., Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype, Int. J. Cancer, vol.83, pp.192-196, 1999.

Z. M. Yuan, H. Shioya, T. Ishiko, X. Sun, J. Gu et al., p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage, Nature, vol.399, pp.814-817, 1999.

A. I. Zaika, S. Kovalev, N. D. Marchenko, and U. M. Moll, Overexpression of the wild type p73 gene in breast cancer tissues and cell lines, Cancer Res, vol.59, pp.3257-3263, 1999.

W. Zhang, G. Hu, E. Estey, J. Hester, and A. Deisseroth, Altered conformation of the p53 protein in myeloid leukemia cells and mitogenstimulated normal blood cells, Oncogene, vol.7, pp.1645-1647, 1992.

J. Zhu, J. Jiang, W. Zhou, and X. Chen, The potential tumor suppressor p73 differentially regulates cellular p53 target genes, Cancer Res, vol.58, pp.5061-5065, 1998.